• Nenhum resultado encontrado

Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies.

N/A
N/A
Protected

Academic year: 2017

Share "Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies."

Copied!
7
0
0

Texto

Loading

Imagem

Figure 1. IL-2 activated human NK cells can kill multiple targets. IL-2 activated primary human NK cells were co-incubated with 51 Cr labeled 221 target cells at an E:T ratio of 0.8:1 to 0.05:1 for 4 and 16 hours
Figure 3. Serial killing of tumor cells by NK cells is mediated by Perforin and Granzyme B
Figure 5. Increasing the killing frequency of fresh NK cells by cytokines and Rituximab

Referências

Documentos relacionados

A técnica extra-capsular foi a escolhida para este caso, pelo fato de a facoemulsificação, técnica com melhor taxa de sucesso em pequenos animais (Gelatt & Wilkie,

inactivation of NK cells after interaction with the target cells, and associated the recycling with the lytic potential of the effector cells. These refractory cells only

The tumor cell prolifera- tion rate was assessed by the Ki-67 antigen labeling index (stained cells / 100 cells) in five different fields of the tumor.. Results: Patient 1 was

When appropriately activated, macrophages are capable of killing pathogens and tumor cells by a number of processes that can involve the phagocytosis of foreign particles and the

inactivation of NK cells after interaction with the target cells, and associated the recycling with the lytic potential of the effector cells. These refractory cells only

Figure 2 - Effect of chromate concentration on Cr(VI) reduction by Bacillus sphaericus AND 303 cells immobilized in PVA-alginate.. Cr(VI) reduction was assayed after

jejuni strains isolated from non-human primates during animal management in the Cecal/Fiocruz, RJ, was able to adhere to or invade HeLa cells.. The difference

Finally, we acknowledge the enduring support for the construction and operation of the LHC and the CMS detector provided by the following funding agencies: the Austrian Federal